Long-acting pegylated G-CSF used to decrease incidence of chemotherapy-induced neutropenia. Stimulates proliferation and differentiation of neutrophils to restore bone marrow function.
Binds to G-CSF receptor on hematopoietic cells, stimulating neutrophil production, maturation, and release from bone marrow. Pegylation extends half-life allowing single dose per chemotherapy cycle (approximately 14 days).
Binds to G-CSF receptor on hematopoietic cells, stimulating neutrophil production, maturation, and release from bone marrow. Pegylation extends half-life allowing single dose per chemotherapy cycle (approximately 14 days).
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.
